Reconciliation Of Total Equity (Tables)

6 Months Ended

Jun. 30, 2015

Reconciliation Of Total Equity [Abstract]

Schedule Of Changes In Total Equity

(in thousands):	21st Century Oncology Holdings, Inc. Shareholder’s Equity		Noncontrolling interests - nonredeemable		Total Equity		Noncontrolling interests - redeemable
Balance, December 31, 2014	$	(480,176)	$	23,566	$	(456,610)	$	49,797
Net (loss) income		(79,780)		1,917		(77,863)		2,466
Other comprehensive loss from foreign currency translation		(4,045)		(456)		(4,501)		4
Accretion of Series A convertible redeemable preferred stock to redemption value		(4,011)		—		(4,011)		—
Accrued Series A convertible redeemable preferred stock dividends		(45,534)		—		(45,534)		—
Purchase price fair value of noncontrolling interest		—		—		—		16,733
Purchase and sale of noncontrolling interests		(378)		(738)		(1,116)		626
Proceeds from noncontrolling interest holders		—		3,170		3,170		60
Stock-based compensation		5		—		5		—
Distributions		—		(1,140)		(1,140)		(892)
Balance, June 30, 2015	$	(613,919)	$	26,319	$	(587,600)	$	68,794
Balance, December 31, 2013	$	(93,751)	$	14,533	$	(79,218)	$	15,899
Net (loss) income		(237,705)		903		(236,802)		2,958
Other comprehensive loss from foreign currency translation		(9,735)		(860)		(10,595)		(11)
Purchase price fair value of noncontrolling interest		—		645		645		28,420
Proceeds from issuance of noncontrolling interest		84		1,166		1,250		—
Proceeds from noncontrolling interest holders		—		229		229		—
Stock based compensation		71		—		71		—
Distributions		—		(624)		(624)		(614)
Balance, June 30, 2014	$	(341,036)	$	15,992	$	(325,044)	$	46,652